论文部分内容阅读
目的观察慢性阻塞性肺疾病的临床疗效。方法将78例慢性阻塞性肺疾病患者随机分为两组:多索茶碱治疗组和氨茶碱对照组,观察两组治疗的结果:临床疗效、不良反应等。结果多索茶碱临床总有效率高于对照组。且不良反应发生率低。两组之间有显著差异(P<0.05)。结论多索茶碱是一种安全有效的治疗慢性阻塞性肺疾病的药物。
Objective To observe the clinical effect of chronic obstructive pulmonary disease. Methods A total of 78 patients with chronic obstructive pulmonary disease were randomly divided into two groups: doxofylline group and aminophylline control group, and the results of two groups were observed: clinical efficacy and adverse reactions. Results Doxofylline clinical total efficiency higher than the control group. And the incidence of adverse reactions is low. There was a significant difference between the two groups (P <0.05). Conclusion Doxofylline is a safe and effective drug for the treatment of chronic obstructive pulmonary disease.